iridium has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Liu, X; Liu, Z; Shao, M; Song, S; Wu, Y; Yang, G; Zhang, P | 1 |
| Chen, J; Chen, L; Gao, J; Guo, X; Huang, Z; Li, D; Sun, Z; Tang, H; Yu, W; Zhu, X | 1 |
| Bi, XD; Cui, RB; Gao, F; Li, XL; Wu, XX; Yang, R; Zeng, LZ; Zhang, Y | 1 |
| Che, C; He, X; Liu, B; Liu, J; Liu, X; Liu, Z; Si, M; Song, S; Yang, G; Zhang, J | 1 |
| Chao, H; Chen, Y; Guan, R; Ji, L; Liao, X; Rees, TW; Wang, L; Xie, L; Xiong, K | 1 |
| Felix, R; Hengst, S; Lopez Hänninen, E; Pech, M; Peters, N; Ricke, J; Rühl, R; Streitparth, F; Wieners, G; Wust, P | 1 |
| Crawford, FA; Marks, RD; Reed, CE | 1 |
1 trial(s) available for iridium and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluoroscopy; Forced Expiratory Volume; Humans; Image Processing, Computer-Assisted; Iridium; Lung Neoplasms; Male; Middle Aged; Nausea; Pneumothorax; Prospective Studies; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Tomography, Spiral Computed; Vital Capacity | 2008 |
6 other study(ies) available for iridium and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Humans; Iridium; Lung Neoplasms; Mitochondria; Reactive Oxygen Species | 2022 |
Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Topics: Antineoplastic Agents; Apoptosis; Carbolines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Humans; Iridium; Lung Neoplasms; Mitochondria; Reactive Oxygen Species | 2023 |
Iridium(III)-Based Infrared Two-Photon Photosensitizers: Systematic Regulation of Their Photodynamic Therapy Efficacy.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Humans; Iridium; Lung Neoplasms; Mice; Photochemotherapy; Photosensitizing Agents | 2023 |
Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Cytochromes c; Drug Screening Assays, Antitumor; HeLa Cells; Heterocyclic Compounds; Humans; Iridium; Lung Neoplasms; Lysosomes; Methane; Microscopy, Confocal; Mitochondria; Organometallic Compounds | 2020 |
An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Calreticulin; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Coordination Complexes; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Female; HMGB1 Protein; Humans; Immunogenic Cell Death; Iridium; Lung Neoplasms; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Survival Rate | 2021 |
Use of brachytherapy in lung cancer.
Topics: Brachytherapy; Carcinoma, Non-Small-Cell Lung; Humans; Iodine Radioisotopes; Iridium; Lung Neoplasms; Radioisotopes | 1986 |